DRAGONI, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 409
EU - Europa 365
AS - Asia 184
SA - Sud America 1
Totale 959
Nazione #
US - Stati Uniti d'America 406
IT - Italia 117
IE - Irlanda 84
HK - Hong Kong 74
PL - Polonia 60
SE - Svezia 49
CN - Cina 40
RU - Federazione Russa 27
SG - Singapore 27
JO - Giordania 23
KR - Corea 12
GB - Regno Unito 10
DE - Germania 6
FR - Francia 6
IN - India 6
ES - Italia 2
HN - Honduras 2
VN - Vietnam 2
BE - Belgio 1
BR - Brasile 1
CA - Canada 1
FI - Finlandia 1
HR - Croazia 1
NL - Olanda 1
Totale 959
Città #
Dublin 84
Warsaw 60
Ashburn 59
Hong Kong 52
Chandler 37
Fairfield 32
Moscow 24
Singapore 22
Altamura 20
Lawrence 20
Florence 18
Shanghai 17
Woodbridge 17
West Jordan 16
Cambridge 14
Seattle 14
Beijing 13
Boardman 12
Seoul 12
Kent 11
Boston 10
Buffalo 10
New York 10
Princeton 10
Houston 8
Wilmington 8
Fontebuona 7
London 7
Ann Arbor 4
Bari 4
Bologna 4
Corigliano Calabro 4
Prato 4
Pune 4
Romainville 4
San Diego 4
Turin 4
Washington 4
Falls Church 3
Los Angeles 3
Viareggio 3
Barcelona 2
Bergamo 2
Cagliari 2
Castelli Calepio 2
Cerro al Volturno 2
Dong Ket 2
Farra di Soligo 2
La Ceiba 2
Medford 2
Montepulciano 2
Naples 2
Norwalk 2
Paris 2
Perugia 2
Sarcedo 2
Scandicci 2
Seelow 2
Wakefield 2
Aci Catena 1
Acton 1
Americana 1
Bremen 1
Brussels 1
Chennai 1
Corciano 1
Core 1
Cornaredo 1
Hounslow 1
La Spezia 1
Lappeenranta 1
Pasadena 1
Pescara 1
Phoenix 1
Pieve 1
Pisa 1
Redwood City 1
Rome 1
San Mateo 1
Stirling 1
Toronto 1
Venturina 1
Totale 732
Nome #
NUCLEAR ORPHAN RECEPTOR COUP-TF2 INCREASED THE RESISTANCE TO ANIKOISIS AND THE METASTATIC POTENTIAL IN HEPATOCELLULAR CARCINOMA 145
GLIM Criteria for Malnutrition in Surgical IBD Patients: A Pilot Study 63
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 57
Effect of long-lasting nutritional prehabilitation on postoperative outcome in elective surgery for IBD 57
CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib 56
Non-small-bowel lesions identification by capsule endoscopy: A single centre retrospective study 49
Clinical efficacy and safety of golimumab in biologically experienced and naive patients with active ulcerative colitis: A real-life experience from two Italian IBD centers 42
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 38
Nutritional adequacy in surgical IBD patients 36
Practical insights into chronic management of hepatic Wilson's disease 33
Relationship between nutritional screening tools and glim in complicated IBD requiring surgery 33
Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey 32
RuvBL1 haploinsufficiency improves mTOR-driven NASH-HCC development in mice 31
Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives 31
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 30
Higher volume growth rate is associated with development of worrisome features in patients with branch duct-intraductal papillary mucinous neoplasms 28
Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study 28
Is the age at surgery in Crohn's disease clinically relevant? Differences and peculiarities: a wide single centre experience after long-term follow-up 27
Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel disease 25
Metabolic disorders across hepatocellular carcinoma in Italy 22
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 21
Main factors influencing long-term outcomes of liver transplantation in 2022 19
RUVBL1 correlates with chaperones expression in HCC and its activity is required for HSF1-mediated stress response 19
RuvBL1 haploinsufficiency promotes hepatic lipid catabolism hampering NASH-HCC progression in mice 17
Gastric Antral Vascular Ectasia (GAVE) a case report, review of the literature and update of techniques 11
T.03.4 SPHINGOSINES, COUP-TFII AND PANCREATIC CANCER 9
Targeting the AAA+ ATPase RuvBL1 reduces mTOR-driven NASH-HCC development in mice 9
Schistosomiasis in non-endemic areas: Italian consensus recommendations for screening, diagnosis and management by the Italian Society of Tropical Medicine and Global Health (SIMET), endorsed by the Committee for the Study of Parasitology of the Italian Association of Clinical Microbiologists (CoSP-AMCLI), the Italian Society of Parasitology (SoIPa), the Italian Society of Gastroenterology and Digestive Endoscopy (SIGE), the Italian Society of Gynaecology and Obstetrics (SIGO), the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV), the Italian Society of General Medicine and Primary Care (SIMG), the Italian Society of Infectious and Tropical Diseases (SIMIT), the Italian Society of Pediatrics (SIP), the Italian Society of Paediatric Infectious Diseases (SITIP), the Italian Society of Urology (SIU) 8
OC.05.6: TARGETING RUVBL1 REDUCES MTOR-DRIVEN NASH-HCC DEVELOPMENT IN MICE 6
Targeting RuvBL1 reduces mTOR-driven NASH-HCC progression in conditional PTEN-KO mice 5
Correlation of Ultrasound Scores with Endoscopic Activity in Crohn's Disease: A Prospective Exploratory Study 3
Branch duct-intraductal papillary mucinous neoplasms (BD-IPMNs): an MRI-based radiomic model to determine the malignant degeneration potential 3
MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing? 2
Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches? 2
Applicability of the International Bowel Ultrasound Segmental Activity Score (IBUS-SAS) to ulcerative colitis: a preliminary study 2
Totale 999
Categoria #
all - tutte 6.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.715


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 2 6 2 3 9 5 4 8 4 5 6 3
2020/2021109 3 16 7 17 4 3 7 10 15 16 5 6
2021/202272 1 6 7 1 2 7 0 4 7 6 10 21
2022/2023350 14 50 15 7 27 64 52 23 49 23 22 4
2023/2024365 8 26 29 18 24 48 22 71 10 56 35 18
2024/202538 38 0 0 0 0 0 0 0 0 0 0 0
Totale 999